We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+3.26%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
AUM
$2.15B
AUM Growth
-$335M
Cap. Flow
-$389M
Cap. Flow %
-18.09%
Top 10 Hldgs %
37.94%
Holding
52
New
2
Increased
1
Reduced
41
Closed

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$23.1M
2
CELG
Celgene Corp
CELG
+$20.1M
3
V icon
Visa
V
+$20.1M
4
FDX icon
FedEx
FDX
+$19.6M
5
DD
Du Pont De Nemours E I
DD
+$17.7M

Sector Composition

Rank Sector Weight
1 Healthcare 20.96%
2 Industrials 14.6%
3 Communication Services 12.19%
4 Energy 12.16%
5 Utilities 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADM icon
51
Archer Daniels Midland
ADM
$38.4B
$296K 0.01%
+5,700
New +$284K
ZBH icon
52
Zimmer Biomet
ZBH
$18.7B
$284K 0.01%
2,575
-8,137
-76% -$858K

Similar funds

Stralem & Co's Q4 2014 Portfolio in Review

As of Q4 2014, Stralem & Co held 52 positions worth $2.15B, down 13% from $2.49B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Stralem & Co withdrew a net $389M in Q4 2014, reducing 41 holdings. Its largest reduction was Amgen, cutting an estimated $23.1M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Stralem & Co opened a new position in KRAFT FOODS GROUP INC COM STK (VA) worth $526K.

  • Stralem & Co's largest Q4 2014 buy was KRAFT FOODS GROUP INC COM STK (VA): 8,400 shares worth $526K.
  • Stralem & Co added most to APA Corp in Q4 2014, an estimated $7.12M increase.
  • Stralem & Co's biggest Q4 2014 reduction was Amgen, cutting an estimated $23.1M.
  • Stralem & Co's ten largest holdings make up 38% of its $2.15B portfolio in Q4 2014.
  • Stralem & Co opened 2 new positions and closed 0 in Q4 2014.
  • Stralem & Co's portfolio value fell 13% quarter-over-quarter to $2.15B.

Based on Stralem & Co's 13F filing for Q4 2014, filed 16 Jan 2015.